SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVAX Insider Trading
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: flickerful who wrote (71)9/27/1997 9:00:00 PM
From: John McCarthy   of 756
 
Randy -

Hi.

I do not follow IVAX.

The only thing I can tell you is that at the
6 month Barron's RoundTable get-together, 2 of
the main guru's recommended Ivax - I think it
was at 10 at the time. And - I think - one
of those guru's was Mike Price.

Their basis for picking it was it was too low and
that Mr. X (can't recall his name) would shake up the
company to get it going again.

I follow the thread here because I have a large
position in NPRO. And, as you know, both companies
are in bed together trying to get around both the
FDA and *MORE IMPORTANTLY* Bristol Myers Squibb's
monopoly on Taxol.

In short, BMS's orphan drug position for Taxol with respect to
K.S. will probably keep Paxene off the market.

If you know any Aid's activist's please let them know
that they are NOT going to be able to buy PAXENE because
BMS and the FDA are going to *probably* squash PAXENE.

To put this in perspective, BMS just told the
*country* of Japan, no, with respect to Taxol because
they did not accept the price offered to them from
the Japanese national health office.

Of course, every company has the right to do this,
but BMS is not every company and therefore CAN DO THIS.

That's about it.

Regards,

John McCarthy
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News